Vaginal suppositories containingLactobacillus acidophilus: development and characterization
- 2 September 2014
- journal article
- Published by Taylor & Francis in Drug Development and Industrial Pharmacy
- Vol. 41 (9) , 1518-1525
Abstract
Objective: The aim of this study was to develop and characterize suppositories for vaginal delivery of Lactobacillus acidophilus. Methods: Formulations were performed in order to select suitable excipients based on suppository formation feasibility and cytotoxicity. Solid body and hollow-type suppositories were prepared by melting and molding using poly(ethylene glycol) (PEG) 400 and 4000 or Witepsol (WIT) H12 as excipients. L. acidophilus was incorporated in the molten mass before molding solid body suppositories or added as suspension into the cavity of hollow-type suppositories and sealed molten excipients. Cytotoxicity of the selected excipients was evaluated by 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium and lactate dehydrogenase assays against VK2/E6E7, HEC-1-A and HeLa cells. Suppositories were characterized regarding organoleptic characteristics, mass uniformity, disintegration, breaking strength and L. acidophilus in vitro release. Results: PEG 400, PEG 4000 and WIT H12 showed the absence of toxicity when tested using three different vaginal cell lines. Obtained vaginal suppositories presented uniform and mild texture, a content of about 1 × 108 colony-forming units, completely disintegrated in simulated vaginal environment in less than 60 min and provided sustained in vitro release of L. acidophilus. Release studies further demonstrated that incorporation of freeze-dried bacteria did not result in significant loss of viable bacteria, thus supporting that vaginal suppositories may possess good properties to promote the replacement of the vaginal flora in situations of urinary tract infection. Conclusion: Hollow-type suppositories showed to be promising delivery vehicles for vaginal delivery of probiotics.Keywords
This publication has 45 references indexed in Scilit:
- Efficacy of orally applied probiotic capsules for bacterial vaginosis and other vaginal infections: a double-blind, randomized, placebo-controlled studyEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 2013
- Advances in development, scale-up and manufacturing of microbicide gels, films, and tabletsAntiviral Research, 2010
- In Vitro Evaluation of Viability, Integrity, and Inflammation in Genital Epithelia upon Exposure to Pharmaceutical Excipients and Candidate MicrobicidesAntimicrobial Agents and Chemotherapy, 2010
- In vitro inhibitory activity of human vaginal lactobacilli against pathogenic bacteria associated with bacterial vaginosis in Kenyan womenAnaerobe, 2010
- Genes and Molecules of Lactobacilli Supporting Probiotic ActionMicrobiology and Molecular Biology Reviews, 2008
- Viability and biological properties of probiotic vaginal lactobacilli after lyophilization and refrigerated storage into gelatin capsulesProcess Biochemistry, 2006
- The vagina as a route for systemic drug deliveryJournal of Controlled Release, 2005
- The safety of pharmaceutical excipientsIl Farmaco, 2003
- Probiotics in man and animalsJournal of Applied Bacteriology, 1989
- Pharmaceutical evaluation of hollow type suppositories. IV. Improvement of bioavailability of propranolol in rabbits after rectal administration.Journal of Pharmacobio-Dynamics, 1986